Bank of Montreal’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$144M Sell
2,369,085
-247,146
-9% -$14.4M 0.05% 281
2025
Q4
$141M Buy
2,616,231
+162,870
+7% +$7.84M 0.05% 295
2025
Q3
$111M Buy
2,453,361
+124,506
+5% +$5.81M 0.04% 305
2025
Q2
$108M Sell
2,328,855
-308,612
-12% -$15.1M 0.05% 254
2025
Q1
$161M Sell
2,637,467
-349,103
-12% -$20.3M 0.08% 183
2024
Q4
$169M Sell
2,986,570
-171,554
-5% -$9.59M 0.08% 189
2024
Q3
$161M Sell
3,158,124
-82,431
-3% -$3.87M 0.07% 214
2024
Q2
$147M Sell
3,240,555
-478,929
-13% -$21.4M 0.04% 227
2024
Q1
$198M Buy
3,719,484
+130,099
+4% +$6.63M 0.06% 181
2023
Q4
$184M Buy
3,589,385
+172,918
+5% +$9.08M 0.06% 186
2023
Q3
$204M Buy
3,416,467
+264,703
+8% +$16.2M 0.07% 152
2023
Q2
$209M Sell
3,151,764
-431,904
-12% -$29M 0.07% 144
2023
Q1
$254M Buy
3,583,668
+445,309
+14% +$31.4M 0.1% 117
2022
Q4
$249M Buy
3,138,359
+83,823
+3% +$6.32M 0.11% 120
2022
Q3
$219K Buy
3,054,536
+172,803
+6% +$12.5M 0.09% 130
2022
Q2
$232K Buy
2,881,733
+30,401
+1% +$2.32M 0.11% 135
2022
Q1
$210M Sell
2,851,332
-497,846
-15% -$33.4M 0.1% 151
2021
Q4
$209M Sell
3,349,178
-3,068,627
-48% -$180M 0.11% 150
2021
Q3
$421M Sell
6,417,805
-126,349
-2% -$8.32M 0.19% 96
2021
Q2
$441M Buy
6,544,154
+1,254,697
+24% +$81.8M 0.22% 88
2021
Q1
$327M Sell
5,289,457
-2,028,786
-28% -$126M 0.21% 93
2020
Q4
$475M Buy
7,318,243
+1,424,994
+24% +$87.6M 0.31% 67
2020
Q3
$340M Buy
5,893,249
+274,005
+5% +$16.5M 0.28% 76
2020
Q2
$327M Buy
5,619,244
+624,617
+13% +$37.4M 0.3% 74
2020
Q1
$276M Buy
4,994,627
+312,926
+7% +$19.1M 0.32% 69
2019
Q4
$301M Buy
4,681,701
+2,581,113
+123% +$148M 0.23% 86
2019
Q3
$107M Sell
2,100,588
-14,796
-0.7% -$695K 0.09% 188
2019
Q2
$95.9M Sell
2,115,384
-2,179,504
-51% -$102M 0.08% 217
2019
Q1
$205M Sell
4,294,888
-754,095
-15% -$37.6M 0.18% 110
2018
Q4
$262M Sell
5,048,983
-813,179
-14% -$43.7M 0.25% 83
2018
Q3
$364M Buy
5,862,162
+97,503
+2% +$5.79M 0.29% 64
2018
Q2
$319M Buy
5,764,659
+109,630
+2% +$5.92M 0.26% 69
2018
Q1
$358M Buy
5,655,029
+1,037,899
+22% +$66.8M 0.32% 59
2017
Q4
$283M Buy
4,617,130
+1,045,359
+29% +$65.4M 0.25% 79
2017
Q3
$228M Buy
3,571,771
+334,207
+10% +$19.5M 0.21% 96
2017
Q2
$180M Sell
3,237,564
-1,392,705
-30% -$75.8M 0.17% 118
2017
Q1
$252M Buy
4,630,269
+2,558,035
+123% +$140M 0.24% 90
2016
Q4
$117M Sell
2,072,234
-579,897
-22% -$31.7M 0.12% 154
2016
Q3
$143M Buy
2,652,131
+548,345
+26% +$35.2M 0.16% 128
2016
Q2
$155M Buy
2,103,786
+1,080,503
+106% +$76.3M 0.18% 112
2016
Q1
$65.4M Buy
1,023,283
+59,059
+6% +$3.72M 0.07% 197
2015
Q4
$66.3M Buy
964,224
+109,536
+13% +$7.24M 0.08% 200
2015
Q3
$50.6M Sell
854,688
-269,043
-24% -$17.1M 0.07% 244
2015
Q2
$74.8M Sell
1,123,731
-710,543
-39% -$46.8M 0.09% 210
2015
Q1
$118M Sell
1,834,274
-181,888
-9% -$11.4M 0.14% 145
2014
Q4
$119M Buy
2,016,162
+1,271,555
+171% +$71.7M 0.13% 139
2014
Q3
$38.1M Buy
744,607
+16,538
+2% +$826K 0.04% 332
2014
Q2
$35.3M Sell
728,069
-41,018
-5% -$2.02M 0.04% 327
2014
Q1
$40M Buy
769,087
+38,120
+5% +$2.03M 0.05% 270
2013
Q4
$38.9M Sell
730,967
-210,319
-22% -$10.7M 0.05% 264
2013
Q3
$43.6M Buy
941,286
+61,270
+7% +$2.69M 0.07% 212
2013
Q2
$39.3M Buy
+880,016
New +$38.2M 0.07% 214

Other funds holding BMY

Bank of Montreal's BMY Position: Q1 2026 in Review

Bank of Montreal reduced its Bristol-Myers Squibb (BMY) stake by 9.4% in Q1 2026, selling an estimated $14.4M and leaving 2,369,085 shares worth $144M. The position accounts for 0.05% of the portfolio, ranked #281.

Bank of Montreal first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $475M in Q4 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank of Montreal held 2,369,085 shares of Bristol-Myers Squibb worth $144M as of Q1 2026.
  • Bank of Montreal sold 247,146 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.4M.
  • Bristol-Myers Squibb made up 0.05% of Bank of Montreal's portfolio in Q1 2026, its #281 holding.
  • Bank of Montreal first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Bristol-Myers Squibb position peaked at $475M in Q4 2020.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.